Does LISINOPRIL Cause Malignant neoplasm progression? 50 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Malignant neoplasm progression have been filed in association with LISINOPRIL (Lisinopril). This represents 0.1% of all adverse event reports for LISINOPRIL.
50
Reports of Malignant neoplasm progression with LISINOPRIL
0.1%
of all LISINOPRIL reports
17
Deaths
18
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LISINOPRIL?
Of the 50 reports, 17 (34.0%) resulted in death, 18 (36.0%) required hospitalization, and 3 (6.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISINOPRIL. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does LISINOPRIL Cause?
Angioedema (5,370)
Drug hypersensitivity (3,779)
Cough (2,527)
Completed suicide (2,246)
Drug ineffective (2,208)
Acute kidney injury (2,022)
Dyspnoea (1,856)
Dizziness (1,758)
Hypotension (1,750)
Fatigue (1,549)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LISINOPRIL Alternatives Have Lower Malignant neoplasm progression Risk?
LISINOPRIL vs LISOCABTAGENE MARALEUCEL
LISINOPRIL vs LITHIUM
LISINOPRIL vs LIXISENATIDE
LISINOPRIL vs LOBAPLATIN
LISINOPRIL vs LOFEXIDINE